Join
Live feed
·
PRReleasevia Quantisnow
iTeos Therapeutics Inc. logo

iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right

ByQuantisnow·Wall Street's wire, on your screen.
ITOS· iTeos Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITOS (iTeos Therapeutics Inc.) and more on Quantisnow.